The Food and Drug Administration granted expedited approval to Eli Lilly's daily weight loss pill, Foundayo.Known chemically as orforglipron, this medication is the second oral GLP-1 drug authorized in the USA.Unlike injectable alternatives, Foundayo is a small-molecule drug that does not require dietary fasting.Clinical trials involving three thousand adults demonstrated an average weight loss of eleven percent.